No Image

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages iLearningEngines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AILE

November 21, 2024 Web Desk 0

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iLearningEngines, Inc. (NASDAQ: AILE) between April 22, 2024 and August 28, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased iLearningEngines securities during […]

No Image

BMBL DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Bumble Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – BMBL

November 21, 2024 Web Desk 0

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bumble Inc. (NASDAQ: BMBL) between November 7, 2023 and August 7, 2024, both dates inclusive (the “Class Period”), of the important November 25, 2024 lead plaintiff deadline. SO WHAT: If you purchased Bumble securities during […]

No Image

ROSEN, LEADING INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HUMA

November 21, 2024 Web Desk 0

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has […]

No Image

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 21, 2024 Web Desk 0

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 20, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will participate in the […]